← Back to Clinical Trials
Recruiting NCT07028333

NCT07028333 Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07028333
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Mental Retardation
Study Type INTERVENTIONAL
Enrollment 33 participants
Start Date 2024-11-15
Primary Completion 2025-07-05

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Motor-Motor Dual Task Exercise GroupMotor-Cognitive Dual Task Exercise GroupControl Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 33 participants in total. It began in 2024-11-15 with a primary completion date of 2025-07-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to investigate the effects of motor-motor and motor-cognitive dual-task exercises applied to children with mild mental retardation on their functional mobility, balance, cognitive function, and quality of life.

Eligibility Criteria

Inclusion Criteria: * Obtaining parental consent * Having an Intelligence Quotient between 51-70 * Having an educational diagnosis of mild mental retardation * Being between the ages of 8-12 * Ability to understand Turkish instructions * Ability to follow commands during the exercise program * No additional disabilities that would prevent participation in the program Exclusion Criteria: * Having a metabolic or systemic disease * Engaging in regular physical exercise * Having visual or hearing impairments * Presence of any condition that would interfere with compliance to assessment parameters

Contact & Investigator

Central Contact

Melike N AKGÖĞ, MScStudent

✉ melikenurakgog@ogr.iuc.edu.tr

📞 +90 535 548 69 73

Principal Investigator

Melike N AKGÖĞ, MScStudent

PRINCIPAL INVESTIGATOR

Istanbul University - Cerrahpasa

Frequently Asked Questions

Who can join the NCT07028333 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Mental Retardation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07028333 currently recruiting?

Yes, NCT07028333 is actively recruiting participants. Contact the research team at melikenurakgog@ogr.iuc.edu.tr for enrollment information.

Where is the NCT07028333 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07028333 clinical trial?

NCT07028333 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Melike N AKGÖĞ, MScStudent at Istanbul University - Cerrahpasa. The trial plans to enroll 33 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology